Skip to main content
. 2022 Jun 30;14(13):3226. doi: 10.3390/cancers14133226

Figure 1.

Figure 1

Pulmonary toxicity. The comparison of pulmonary toxicity in a time-to-event analysis revealed no significant difference (log-rank test, p-value = 0.353) between high-dose chemoradiation and standard of care (CRT = chemoradiotherapy, SoC = standard of care).